NCT00354406View on ClinicalTrials.gov

Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Myocardial Infarction
Interventions
DRUG

abciximab

standard i.v. bolus of abciximab is administered at time of randomization in arm A, and at time of primary angioplasty in arm B.

Trial Locations (1)

56124

Cardiothoracic Department, Ospedale Cisanello, Pisa

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Pisa

OTHER

NCT00354406 - Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty | Biotech Hunter | Biotech Hunter